Serum concentrations after switching from originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease (SECURE): an open-label, multicentre, phase 4 non-inferiority trial
Titel:
Serum concentrations after switching from originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease (SECURE): an open-label, multicentre, phase 4 non-inferiority trial
Auteur:
Strik, Anne S van de Vrie, Wim Bloemsaat-Minekus, Joanne P J Nurmohamed, Michael Bossuyt, Peter J J Bodelier, Alexander Rispens, Theo van Megen, Yvonne J B D'Haens, Geert R